Scarica l'app Stockscreener
1.095
12.37%
0.125
Precedente Chiudi:
$0.97
Aprire:
$1.06
Volume 24 ore:
101.71K
Relative Volume:
2.53
Capitalizzazione di mercato:
$18.46M
Reddito:
$48.43M
Utile/perdita netta:
$-11.04M
Rapporto P/E:
-1.6343
EPS:
-0.67
Flusso di cassa netto:
$-7.00M
1 W Prestazione:
-13.49%
1M Prestazione:
-29.68%
6M Prestazione:
-45.77%
1 anno Prestazione:
-57.92%
Intervallo 1D:
$1.06
$1.1431
Intervallo di 1 settimana:
$0.96
$1.3657
Portata 52W:
$0.96
$3.65
Iridex Corp Stock (IRIX) Company Profile
Nome
Iridex Corp
Settore
Industria
Telefono
(650) 940-4700
Indirizzo
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Confronta IRIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.095 | 18.46M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
126.34 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.76 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.86 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.06 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.63 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2017-11-03 | Ripresa | ROTH Capital | Buy |
| 2016-12-21 | Iniziato | ROTH Capital | Buy |
| 2016-01-26 | Iniziato | Singular Research | Buy |
| 2007-01-03 | Iniziato | First Albany | Buy |
Iridex Corp Borsa (IRIX) Ultime notizie
Iridex addresses recent stock volatility - Investing.com
Iridex Comments on Recent Stock Price Volatility - Yahoo Finance
Iridex Corporation to Announce Q4 and Full Year 2024 Financial Results on March 27, 2025 - Nasdaq
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - Yahoo Finance
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research - GlobeNewswire Inc.
Iridex reports steady Q4 sales, eyes profitability in 2025 - Investing.com
Iridex Reports Mixed Q4 Results: Revenue Up, Achieves Positive EBITDA Amid Strategic Review - StockTitan
IRIDEX (NASDAQ:IRIX) Stock Passes Below 200 Day Moving Average – Time to Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - Yahoo Finance
Iridex Announces Milestone Five-Year Study Confirms the - GlobeNewswire
Medical Lasers Market Focused Insights 2024-2029: Mergers, - GlobeNewswire
Veterinary Eye Care Market to Grow by USD 1.05 Billion (2024-2028), Report on AI-Powered Market Evolution and Rising Pet OwnershipTechnavio - The Malaysian Reserve
United States Retinal Surgery Devices Market - GlobeNewswire
IRIX Stock Surges Over 6% Amidst Medical Device Sector Decline - GuruFocus.com
Advancing Healthcare Tech: Medical Lasers Market Report 2024 - WhaTech
IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript - MSN
Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits | IRIX Stock News - StockTitan
IRIDEX Corp adjusts executive compensation, reshuffles board By Investing.com - Investing.com Australia
IRIDEX Corp adjusts executive compensation, reshuffles board - Investing.com India
3 US Penny Stocks With Market Caps Under $50M To Watch - Yahoo Finance
IRIDEX earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic M - GuruFocus.com
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... - Yahoo Finance
Iridex: Q3 Earnings Snapshot - The Washington Post
Iridex Q3 Revenue Falls 10% YoY, Aims for Q4 EBITDA Breakeven Amid Strategic Review | IRIX Stock News - StockTitan
Iridex Reports Third Quarter 2024 Financial Results - Yahoo Finance
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
IRIX Stock Sees Significant Drop Amid Market Fluctuation - GuruFocus.com
IRIDEX Co. (NASDAQ:IRIX) Short Interest Up 9.9% in October - Defense World
Ophthalmic Photocoagulator Market to Witness Huge Growth by 2032 |Alcon, NIDEK, IRIDEX, Lumenis Be - openPR
IRIDEX (NASDAQ:IRIX) Research Coverage Started at StockNews.com - Defense World
Ophthalmology Devices Market projected to grow by USD 19.1 Billion from 2024-2028, driven by AI-powered innovations and rising prevalence of ophthalmic diseasesTechnavio - The Malaysian Reserve
IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Morphotonics Appoints CEO: People in the News: 10/9/24 | Business | Oct 2024 - Photonics.com
IRIX stock touches 52-week low at $1.62 amid market challenges By Investing.com - Investing.com South Africa
IRIX stock touches 52-week low at $1.62 amid market challenges - Investing.com Australia
Iridex names Patrick Mercer as new CEO to drive strategic review - Investing.com
Iridex Appoints Patrick Mercer as Chief Executive Officer - StockTitan
Iridex Corp Azioni (IRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):